Zobrazeno 1 - 10
of 139
pro vyhledávání: '"carbapenem sparing"'
Autor:
Carlo Pallotto, Andrea Tommasi, Elisabetta Svizzeretto, Giovanni Genga, Giulia Gamboni, Anna Gidari, Daniela Francisci
Publikováno v:
Infectious Disease Reports, Vol 16, Iss 5, Pp 828-835 (2024)
Background. Pseudomonas aeruginosa is one of the major concerns among bacterial diseases even when it shows a wild-type susceptibility pattern. In 2020, EUCAST reconsidered antibiogram interpretation shifting “I” from “intermediate” to “sen
Externí odkaz:
https://doaj.org/article/3fe547d543f343e8b296a6fa95b21b33
Autor:
David Mokrani, Juliette Chommeloux, Marc Pineton de Chambrun, Guillaume Hékimian, Charles-Edouard Luyt
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-19 (2023)
Abstract Antibiotic resistance is a major health problem and will be probably one of the leading causes of deaths in the coming years. One of the most effective ways to fight against resistance is to decrease antibiotic consumption. Intensive care un
Externí odkaz:
https://doaj.org/article/e0767357779d4abf851cefd6a3cf9e91
Autor:
Silvia Corcione, Ilaria De Benedetto, Massimiliano Carlin, Emanuele Emilio Pivetta, Silvia Scabini, Cecilia Grosso, Nour Shbaklo, Massimo Porta, Enrico Lupia, Francesco Giuseppe De Rosa
Publikováno v:
Microorganisms, Vol 12, Iss 4, p 725 (2024)
Ceftobiprole is a fifth-generation cephalosporin approved by European and American regulatory agencies for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Ceftobiprole administration is useful in severe CAP
Externí odkaz:
https://doaj.org/article/6db130b07bd24018b4386c9a5f70f932
Autor:
Paul Chabert, Judith Provoost, Sabine Cohen, Céline Dupieux-Chabert, Laurent Bitker, Tristan Ferry, Sylvain Goutelle, Jean-Christophe Richard
Publikováno v:
Annals of Intensive Care, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Background Cefoxitin is active against some extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE), but has not been evaluated so far in the intensive care unit (ICU) settings. Data upon its pharmacokinetics (PK), tolerance an
Externí odkaz:
https://doaj.org/article/7ba14b2686d2460aba013f46de1c987c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Camille Le Berre, Marion Houard, Anne Vachée, Hugues Georges, Frederic Wallet, Pierre Patoz, Patrick Herbecq, Saad Nseir, Pierre-Yves Delannoy, Agnès Meybeck
Publikováno v:
Microorganisms, Vol 11, Iss 11, p 2676 (2023)
National and international guidelines were recently published regarding the treatment of Enterobacteriaceae resistant to third-generation cephalosporins infections. We aimed to assess the implementation of the French guidelines in critically ill pati
Externí odkaz:
https://doaj.org/article/450ddc7257014eff94e7399dcbe472e9
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 3-4, Pp 82-98 (2021)
Cefepime/sulbactam is a combined antibiotic consisting of the 4 th generation cephalosporin cefepime and the beta-lactamase inhibitor sulbactam in 1:1 ratio. Cefepime/sulbactam antibiotic was developed in Russia in 2006, it had passed preclinical and
Externí odkaz:
https://doaj.org/article/143f840f140c42408d729fa3b495d8a7
Autor:
S. V. Yakovlev, M. P. Suvorova, A. O. Bykov, S. V. Zhuravel, K. A. Popugaev, L. Yu. Kulagina, I. N. Ochakovskaya, M. G. Fedorova, O. V. Pribytkova, A. A. Zateyshchikova, O. G. Malkova, T. N. Malorodova, E. S. Nekaeva, N. G. Ogonkin, Yu. A. Strezh, I. N. Sychev, O. I. Tazieva, S. G. Fominykh
Publikováno v:
Антибиотики и Химиотерапия, Vol 65, Iss 11-12, Pp 49-58 (2021)
The aim of the study was to evaluate the effectiveness of cefepime/sulbactam in patients with intra-abdominal infection, nosocomial pneumonia (NP) or ventilator-associated pneumonia (VAP) in actual clinical practice. Material and methods. The study w
Externí odkaz:
https://doaj.org/article/a99b4fea45ec4f7ebd0101f21d7b02c1
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Ineffective antibiotic therapy increases mortality of acute cholangitis. The choice of antibiotics should reflect local resistance patterns and avoid the overuse of broad-spectrum agents. In this study, we analysed how results of
Externí odkaz:
https://doaj.org/article/011c9782cfed47ef8c0d09e23e4656b1